Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa‐Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers
Movement Disorders · 2026-07 · 41 (7) · 1716-1726
DOI: 10.1002/mds.70332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 26.04.2026. Verfasst von Jannik Prasuhn und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Movement Disorders, Department of Neurology, University Medical Center Schleswig-Holstein (UKSH), Campus Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Cerebellum, Basal Ganglia, Dystonic Disorders, GTP Cyclohydrolase. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Deutschen Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Dopa‐responsive dystonia is caused by pathogenic variants in the GCH1 gene. Although its clinical features and reduced penetrance are known, in vivo metabolic and structural alterations in symptomatic (sMC) and asymptomatic mutation carriers (aMC) remain poorly understood.
Objectives
The aims were to characterize the volumetric and neurometabolic brain changes in GCH1 mutation carriers (MC) and explore their relationship with clinical severity.
Methods
We studied 20 sMCs, 5 aMCs, and 25 mutation‐free healthy controls (HC) using volumetric magnetic resonance imaging (MRI) combined with 31 phosphorus magnetic resonance spectroscopy imaging ( 31 P‐MRSI) of the basal ganglia and cerebellum. Analysis of covariance (ANCOVA) was used for group comparisons, and correlations were assessed using clinical symptom severity rating scales.
Results
Volumetric analyses revealed enlarged globus pallidus (16.6%, P = 0.0010) and putamen (7.2%, P = 0.0310) volumes in sMCs and increased cerebellar gray matter in aMCs (8.0%, P = 0.0500). Nicotinamide adenine dinucleotide (NAD) levels were significantly reduced in the basal ganglia of carriers (NAD/Pi [inorganic phosphate]: −14.7%, P = 0.0460; NAD/ATP‐α: −15.5%, P = 0.0180). In the cerebellum, aMCs demonstrated elevated high‐energy phosphate ratios ([ATP‐α + PCr]/Pi: 23.7%, P = 0.0170; ATP‐α/Pi: 21.3%, P = 0.0460; PCr [phosphocreatine]/Pi: 25.2%, P = 0.0090) compared with sMCs and HCs. Smaller cerebellar volumes correlated with greater dystonia severity (Burke‐Fahn‐Marsden Dystonia Rating Scale, ρ = −0.557, P = 0.0133), whereas lower basal ganglia NAD ratios correlated with higher Movement Disorder Society‐Unified Parkinson's Disease Rating Scale, Part III (ρ = −0.527, P = 0.0204), and Toronto Western Spasmodic Torticollis Rating Scale scores (ρ = −0.475, P = 0.0398).
Conclusions
Volumetric MRI and 31 P‐MRSI reveal region‐ and subgroup‐specific metabolic and structural alterations in GCH1 MCs, linking basal ganglia vulnerability and cerebellar adaptation to clinical severity. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Movement Disorders, Department of Neurology, University Medical Center Schleswig-Holstein (UKSH), Campus Lübeck, Lübeck, Germany.
- Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
- Center for Brain, Behavior and Metabolism, University of Lübeck, Lübeck, Germany.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
- Institute of Systems Motor Science, Center for Rare Diseases, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Marta M Pokotylo, Feline Hamami, Alexander Münchau
Förderung
- NICHD NIH HHS
- Deutschen Forschungsgemeinschaft
Zitieren
APA
Prasuhn, J., van Well, L., Pokotylo, M. M., Hamami, F., Aßmann, J. L., Lohmann, K., Ködderitzsch-Mertins, M. G., Henkel, J., Uter, J., Münchau, A., Klein, C., Weissbach, A., & Brüggemann, N. (2026). Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa‐Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers. Movement Disorders, 41(7), 1716-1726. https://doi.org/10.1002/mds.70332
Vancouver
Prasuhn J, van Well L, Pokotylo MM, Hamami F, Aßmann JL, Lohmann K, et al. Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa‐Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers. Movement Disorders. 2026;41(7):1716-1726. doi:10.1002/mds.70332
BibTeX
@article{Prasuhn2026,
author = {Prasuhn, Jannik and van Well, Leon and Pokotylo, Marta M and Hamami, Feline and Aßmann, Joke-Lina and Lohmann, Katja and Ködderitzsch-Mertins, Maximilian G and Henkel, Julia and Uter, Jan and Münchau, Alexander and Klein, Christine and Weissbach, Anne and Brüggemann, Norbert},
title = {Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa‐Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {7},
pages = {1716--1726},
doi = {10.1002/mds.70332}
}
EUVIMED